SINT Share Price Performance
US$1.71
-1.34 (-43.93%)
71.5% undervalued intrinsic discount
US$6.00
Fair Value
Price US$1.71
AnalystLowTarget US$6.00
Fair ValueUS$6.00
Share Pricen/a
New Narrative • Aug 12
Sintx Technologies, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
SINT Community Narratives
AN
Fair Value
·Fair Value US$6 71.5% undervalued intrinsic discount
High Risk Ceramics Expansion Will Test Outsourced Manufacturing Before Potential Upside Emerges
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
High Risk Ceramics Expansion Will Test Outsourced Manufacturing Before Potential Upside Emerges
Sintx has real demand lined up for its advanced ceramics, but turning that into cash hinges on whether it can reliably make and ship a tricky product while funding a costly ramp-up. At the same time, its newer medical implant line looks promising yet still needs slow, hands-on adoption by surgeons and partners—making the path to upside far from smooth.Read more
AN
US$6
71.5% undervalued intrinsic discount
Fair Value
Profit Margin
12.13%
Future PE
8.26x
Price in 2029
US$4.25
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
High Risk Ceramics Expansion Will Test Outsourced Manufacturing Before Potential Upside Emerges
Fair Value: US$6 71.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Sintx Technologies, Inc. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -4.38
- 52.86%
- -1,423.01%
- 2.1%
About SINT
- Founded
- 1996
- Employees
- 32
- CEO
- WebsiteView website
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
